Digital Therapeutics (DTx) Market – Global Outlook & Forecast 2021-2031

Digital Therapeutics (DTx) Market – Global Outlook & Forecast 2021-2031

Digital Therapeutics Market Introduction

“Digital health” is an umbrella term that’s grown to include everything from electronic health records to wellness apps and clinically validated therapeutic interventions that mirror or improve upon existing in-person therapies. Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs   to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes. DTx products incorporate advanced technology best practices relating to design, clinical validation, usability, and data security. They are reviewed and cleared or approved by regulatory bodies as required to support product claims regarding risk, efficacy, and intended use

Market - Headwinds & Tailwinds

The global digital therapeutics (DTx) market is mainly driven by rising prevalence of chronic diseases, growing geriatric population and significant increase in venture capital investments. Partnerships between companies & clinical institutions for R&D activities are also playing a pivotal role in triggering the market growth globally. However, risk of cybersecurity threats, data privacy concerns of patients, limited awareness and accessibility to digital therapeutics programs in emerging countries, resistance from traditional healthcare providers, and unstable payment models are some of the key challenges that are likely to hinder the growth of the market to a certain extent.

Digital Therapeutics (DTx) Market Report

Market Segmentation & Insights

The global digital therapeutics (DTx) market has been analyzed from three main perspectives: Application, Distribution Channel and Region.

Digital Therapeutics (DTx) Market by Application

Based on application, the digital therapeutics (DTx) market has been segmented into obesity, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, respiratory diseases, smoking cessation and others (skin related disorders, blood related disorders, immunological disorders, cancer, musculoskeletal disorders, etc.). The diabetes segment accounted for the largest share in the market. Patients with chronic diseases like diabetes, require significant changes in lifestyle, regular vigilance, and care. The growth of the segment can be attributed to its growing prevalence, rising awareness regarding the importance of health management in diabetes and incessant launch of digital therapeutic products & solutions with innovative features.

Digital Therapeutics (DTx) Market by Type of Commercial Transaction

Based on type of commercial transaction, the digital therapeutics (DTx) market has been segmented into B2B and B2C. The B2B segment holds the largest share and is expected to be the fastest growing segment during the forecast period. The growth of the segment can mainly be attributed to growing awareness among providers, payors, and employers regarding the benefits provided by digital therapeutics including additional benefit of cost-effectiveness.

Digital Therapeutics (DTx) Market by Region

Based on region, the global digital therapeutics (DTx) market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the digital therapeutics (DTx) market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to the rising prevalence of various lifestyle related diseases such as obesity & diabetes, presence of key prominent players, launch of new products and rising investment for development of digital therapeutics technology.

Competitive Landscape

The digital therapeutics (DTx) market is marked by presence of prominent players such as Voluntis, Teladoc Health, Inc., Omada Health, Inc., 2Morrow Inc., Pear Therapeutics, Inc., Ginger, ResMed, CANARY HEALTH, Welldoc, Proteus Digital Health, Inc. Other players operating in the market are MedRhythms, Merck & Co., Inc., Akili Interactive Labs, Inc., GAIA AG, Click Therapeutics, Inc., among others.

Snapshot: Industry Developments

  • In March 2021, Voluntis, announced a collaboration with Broward Health, a public health system in the U.S. The partnership is aimed to focus on conducting a real-world evaluation of Oleena®, a digital application that assists patients in managing their symptoms
  • In Feb 2021, Otsuka Pharmaceutical partnered with Click Therapeutics to launch a remote clinical trial to evaluate the effectiveness of digital therapeutics in reducing depressive symptoms
  • In Sept 2020, DarioHealth Corp., announced strategic partnership with Williams Medical to make the DarioHealth Remote Patient Monitoring (RPM) digital therapeutics platform available to Healthcare Professionals (HCPs) across the United Kingdom and Ireland
  • In July 2020, Biocon Biologics and Voluntis announced a global collaboration agreement between Biocon Biologics’ subsidiary Biocon Sdn. Bhd., Malaysia and Voluntis to develop and distribute innovative digital therapeutics supporting people with diabetes on biologics therapy

 

Key Insights Captured in the Report

  • Quantitative (market size and forecasts) and qualitative insights of the market across years - historical years, current year and forecasted years
  • Deep-rooted insights on headwinds, tailwinds and opportunities prevailing in the market
  • Quantitative (market size and forecasts) and qualitative insights at segment and sub-segment level
  • Comprehensive quantitative (market size and forecasts) and qualitative insights on geographic, regional and country level markets
  • Granular insights on the competitive landscape prevailing in the market
  • Competitive mapping of strategic developments 

Scope of the Digital Therapeutics Market Report:

Report Metrics Details
Market Size Period 2018-2031
Base Year 2020
Forecast Period 2021-2031
Market Segments Asessment of Digital Therapeutics Market By:
• Application
• Commercial Transaction
• Region
Geographic Scope North America
◦ U.S.
◦ Canada
Europe
◦ Germany
◦ UK
◦ France
◦ Rest of Europe (RoE)
Asia Pacific
◦ China
◦ Japan
◦ India
◦ Rest of Asia Pacific (RoAPAC)
Rest of the World
◦ Latin America
◦ Middle East & Africa
Companies Covered Voluntis, Teladoc Health, Inc., Omada Health, Inc., 2Morrow Inc., Pear Therapeutics, Inc., Ginger, ResMed, CANARY HEALTH, Welldoc, Proteus Digital Health, Inc., MedRhythms, Merck & Co., Inc., Akili Interactive Labs, Inc., GAIA AG, Click Therapeutics, Inc., among others.

1 RESEARCH ENVELOPE

1.1 Market Classification

1.2 Scope of the Study

1.2.1 Timeline Considered for Market Study

· Historic Years – 2018 & 2019

· Base Year – 2020

· Projected Years – 2021 to 2031

1.3 Currency Used in the Report

2 RESEARCH METHODOLOGY

2.1 Research Approach

2.2 Data Collection Methodology

2.3 Data Sources

2.3.1 Secondary Sources

2.3.2 Primary Sources

2.4 Market Crackdown Methodology

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Data Forecasting Model

2.6 Limitations and Assumptions for Study

3 HEADWINDS & TAILWINDS ASSESSMENT

4 MARKET OPPORTUNITIES ASSESSMENT

5 PREMIUM INSIGHTS

5.1 Key Market Trends

5.2 Key Players & Their Competitive Positioning (2020)

5.3 COVID-19 Impact Assessment

6 GLOBAL DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION

6.1 Obesity

6.2 Diabetes

6.3 Central Nervous System (CNS) Disorders

6.4 Cardiovascular Diseases

6.5 Respiratory Diseases

6.6 Smoking Cessation

6.7 Other Applications (Skin Related Disorders, Blood Related Disorders, Immunological Disorders, Cancer, Musculoskeletal Disorders, Etc.)

7 GLOBAL DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE OF COMMERCIAL TRANSACTION

7.1 B2B

7.2 B2C

8 GLOBAL DIGITAL THERAPEUTICS (DTX) MARKET, BY REGION

8.1 North America Digital Therapeutics (DTx) Market

8.1.1 North America Digital Therapeutics (DTx) Market, By Country

8.1.1.1 U.S.

8.1.1.2 Canada

8.1.2 North America Digital Therapeutics (DTx) Market, By Application

8.1.3 North America Digital Therapeutics (DTx) Market, By Type of Commercial Transaction

8.2 Europe Digital Therapeutics (DTx) Market

8.2.1 Europe Digital Therapeutics (DTx) Market, By Country/Region

8.2.1.1 Germany

8.2.1.2 U.K.

8.2.1.3 France

8.2.1.4 Rest of Europe (ROE)

8.2.2 Europe Digital Therapeutics (DTx) Market, By Application

8.2.3 Europe Digital Therapeutics (DTx) Market, By Type of Commercial Transaction

8.3 Asia Pacific Digital Therapeutics (DTx) Market

8.3.1 Asia Pacific Digital Therapeutics (DTx) Market, By Country/Region

8.3.1.1 China

8.3.1.2 Japan

8.3.1.3 India

8.3.1.4 Rest of Asia Pacific (RoAPAC)

8.3.2 Asia Pacific Digital Therapeutics (DTx) Market, By Application

8.3.3 Asia Pacific Digital Therapeutics (DTx) Market, By Type of Commercial Transaction

8.4 Rest of the World (RoW) Digital Therapeutics (DTx) Market

8.4.1 Rest of the World Digital Therapeutics (DTx) Market, By Region

8.4.1.1 Latin America

8.4.1.2 Middle East & Africa

8.4.2 Rest of The World Digital Therapeutics (DTx) Market, By Application

8.4.3 Rest of The World Digital Therapeutics (DTx) Market, By Type of Commercial Transaction

9 COMPANY PROFILES

9.1 Voluntis

9.1.1 Business Overview

9.1.2 Financial Metrics*

9.1.3 Product Portfolio

9.1.4 Key Developments

9.2 Teladoc Health, Inc.

9.3 Omada Health, Inc.

9.4 2Morrow Inc.

9.5 Pear Therapeutics, Inc.

9.6 Ginger

9.7 ResMed

9.8 CANARY HEALTH

9.9 Welldoc

9.10 Proteus Digital Health, Inc.

*Insights on financial metrics is subject to availability of information in the public domain

Download Report Sample PDF

Specific Requirement Form

Solitary

  • The solitary license authorizes only one individual to use the report
  • A PDF version of the report will be delivered that can be viewed on only one authorized system
  • Free analyst support for 20 hours is extended as a value-added service
  • Buyers need to share the ‘Name and Email ID of the authorized user
  • Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research

$4850

Compound

  • Compound license authorizes only 5 individuals to use the report
  •  A PDF/Printable version of report will be delivered that can be viewed on only 5 authorized systems
  • Free analyst support for 40 hours is extended as a value-added service
  • Buyers need to share ‘Names and Email IDs’ of the authorized users 
  • Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research

$5850

Corporate

  • Corporate license authorizes unlimited individuals to use the report
  • A PDF/Printable version of report will be delivered that can be viewed on unlimited systems
  • Free analyst support for 80 hours is extended as a value-added service
  • This license type allows extraction of top-level market data tables in ‘Excel’ format and also permits the buyer to quote the contents of the report published by Clairvoyance Research

$6850

Data Pack

  • Data Pack’ request provides customers all ‘Quantitative Insights’ with respect to a particular market in an excel-based dashboard format

$2250

Purchase Options

Solitary $4850

Compound $5850

Corporate $6850

Data Pack $2250

  • The solitary license authorizes only one individual to use the report
  • A PDF version of the report will be delivered that can be viewed on only one authorized system
  • Free analyst support for 20 hours is extended as a value-added service
  • Buyers need to share the ‘Name and Email ID of the authorized user
  • Imitation, distribution as well as quoting of the contents of the report is prohibited without the prior permission of Clairvoyance Research

Popular Reports

Summer 3E,Purti Season,22 Buroshibtalla Main Road, Near Leela Petrol Pump, Kolkata, West Bengal-700038
+ 91 8761988338
10 AM to 10 PM
info@clairvoyanceresearch.com
Support line
TOP